Showing results (2591-2600 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|September 29, 2025
Single-cell transcriptomic analyses provide insights into SPP1+ TAM-mediated immune suppression and CD8+ T cell dysfunction in lung cancerRahma Taher Almgrami, Tengyue Zhang, Qitai Zhao, et al.
Cancer Immunology, Immunotherapy : CII|July 15, 2025
Concurrent treatment with transarterial immunoembolization of hepatic metastases and systemic immune checkpoint inhibitors to overcome immune evasion in patients with metastatic uveal melanomaNatalie J Miller, Sharon W Kwan, Jacob B Leary, et al.
Cancer Immunology, Immunotherapy : CII|July 15, 2025
Anti-TIGIT therapies: a review of preclinical and clinical efficacy and mechanismsErin C Sundstrom, Xueting Huang, Andrew J Wiemer
Cancer Immunology, Immunotherapy : CII|July 5, 2025
Impact of stratifin/14-3-3σ on survival and interstitial lung disease in patients with non-small cell lung cancer receiving immune checkpoint inhibitorsDaiki Murata, Koichi Azuma, Kenta Murotani, et al.
Cancer Immunology, Immunotherapy : CII|July 5, 2025
Clinical outcomes following PD-1 inhibitor elective discontinuation in cutaneous squamous cell carcinoma: exploring treatment de-escalationItamar Averbuch, Nofar Edri, Nethanel Asher, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2025
Divergent therapeutic and prognostic impacts of immunogenic features in undifferentiated pleomorphic sarcoma and myxofibrosarcomaSiddh van Oost, Debora M Meijer, Zeynep B Erdem, et al.
Cancer Immunology, Immunotherapy : CII|June 25, 2025
Tumor-promoting function of paternally expressed gene 10 and its immunogenicity in inducing anti-tumor helper T cells in head and neck squamous cell carcinomaHiroki Komatsuda, Toshihiro Nagato, Akemi Kosaka, et al.
Cancer Immunology, Immunotherapy : CII|December 24, 2025
A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancerMd Saiful Islam Saif, Kartik Sehgal, Ze Zhang, et al.
Cancer Immunology, Immunotherapy : CII|December 18, 2025
Long-term outcome of neoadjuvant tislelizumab plus chemotherapy in locally advanced esophageal squamous cell carcinomaHao Yin, Xinyu Yang, Yujie Chen, et al.
Cancer Immunology, Immunotherapy : CII|December 19, 2025
Preclinical evaluation of CAR-T cell immunotherapy with a fully human EpCAM-specific scFv against pancreatic cancerYing-Ying Fan, Ya-Ling Liu, Xiao-Fan Liu, et al.
Pageof 652